Pancreatic Cancer Research

ResearcherUniversity of Wisconsin SystemActive in the last 2 years

Lingjun Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0056-3869; OpenAlex author ID A5100746152. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Exploring the interplay between protein conformational changes and phosphorylation in a pancreatic cancer cell and stellate cell coculture system. Last author DOI 10.1073/pnas.2511839122↗
  2. Proteome-Wide Investigation of Proline Hydroxylation in Pancreatic Ductal Adenocarcinoma Using DiLeu Isobaric Labeling Strategy. Last author DOI 10.1016/j.mcpro.2025.100969↗
  3. Mass Defect-Based N,N-Dimethyl Leucine Labels for Quantitative Proteomics and Amine Metabolomics of Pancreatic Cancer Cells. Last author DOI 10.1021/acs.analchem.6b03482↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haiyan Lu · 1 shared paper, 2026 · strength 0.36
  2. Feixuan Wu · 1 shared paper, 2025 · strength 0.33
  3. Weiyuan John Kao · 1 shared paper, 2017 · strength 0.08
  4. Ling Hao · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.